Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
adverse drug reaction
agitation
agitation, childhood, acute
akineton
alpha methyldopa hydrazine
amantadine
aminoglycoside
amitriptyline
amphetamines
ampicillin
anesthesia, general
anterocollis
antiarrhythmic drugs
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinergic poisoning
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
artane
atropine
atropine psychosis
autonomic dysfunction
belladonna
beta adrenergic blocker
bradykinesia
brain damage
calcium antagonist
carbidopa
catatonia
catatonia, lethal
children
chloroquine
chlorpromazine
chorea
ciprofloxacin
clozapine
cogentin
coma
complications
confusion
confusional state, acute
constipation
contrast agents, neurotoxicity of
cooling therapy
creatine phosphokinase(CPK)elevated
cyproheptidine
dehydration
delirium
dementia
deprenyl
dilantin
dopamine
dopamine agonist
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug overdose
drug withdrawal
dyskinesia
dystonia
dystonia, cervical
dystonia, drug induced
dystonia, face
dystonia, focal
dystonia, treatment of
dystonia, truncal
dystonic reaction, acute
emergencies, medical
emergencies, neurologic
enzyme inhibition
erythromycin
exercise
fever
fluoroquinolones
grasping
hallucination
hallucination, visual
haloperidol
heatstroke
herbs
hyperthermia
iatrogenic neurologic disorders
imipramine
interferon
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
leukocytosis
levonorgestrel
lithium
livedo reticularis
liver function enzymes
malignant hyperpyrexia
memory, defect of recent
memory, impairment of
mental status, abnormal
methacholine
migraine
migraine, prophylaxis
misdiagnosis
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, treatment of
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myasthenic syndrome
myoglobinuria
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuromuscular blockade
nicotine
obesity
old age, neurology of
orthostatic hypotension
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, fluctuations in
Parkinson disease, misdiagnosis
Parkinson disease, on-off phenomena in
Parkinson disease, treatment of
parsidol
patient information and support
penicillamine
personality change
phenothiazine
physostigmine
Pisa syndrome
poison, neurologic problems with
prevention of neurologic disorders
procyclidine
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
pupil, abnormality in neurologic disorders
pupil, dilated, bilateral
pyridoxine
quinidine
renal failure
reserpine and reserpine like drugs
retrocollis
review article
rhabdomyolysis
rigidity
risk factors
ritalin
schizophrenia
seizure
serotonin syndrome
sinemet
skin, dry
steroid
tachycardia
tardive dystonia
tea
timolol
toxins, nervous system
tranquilizers, neurologic complications with
treatment of neurologic disorder
tremor
tricyclic antidepressant
verapamil
vertigo
vertigo, treatment of
vision, blurred
vitamin, multiple
xerostomia
Showing articles 1400 to 1450 of 8417 << Previous Next >>

Topiramate in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 71:272-276, Unt,S.,et al., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008

Does Lamotrigine Use in Pregnancy Increase Orofacial Cleft Risk Relative to Other Malformations?
Neurol 71:714-722, Dolk,H.,et al., 2008

Serotonin Syndrome Associated With Triptan Monotherapy
NEJM 358:2185-2186, Soldin,O.P. &Tonning,J.M., 2008

SLC01B1 Variants and Statin-Induced Myopathy -- A Genomewide Study
NEJM 359:789-799, The SEARCH Collaborative Group, 2008

Drowning in People With Epilepsy: How Great is the Risk?
Neurol 71:578-582, Bell,G.S.,et al., 2008

Attempted and Completed Suicides After Subthalamic Nucleus Stimulation for Parkinsons Disease
JNNP 79:952-954, Soulas,T.,et al., 2008

The Alcohol Withdrawal Syndrome
JNNP 79:854-862, McKeon,A.,et al., 2008

Anticoagulation After Cardioembolic Stroke: To Bridge or Not to Bridge
Arch Neurol 65:1169-1173,1157, Hallevi,H.,et al., 2008

Cardiac Involvement in Patients With Limb-Girdle Muscular Dystrophy Type 2 and Becker Muscular Dystrophy
Arch Neurol 65:1196-1201, Sveen,M.-L.,et al., 2008

Association Between Cerebral Microbleeds on T2*-Weighted MR Images and Recurrent Hemorrhagic Stroke in Patients Treated With Warfarin Following Ischemic Stroke
AJNR 29:1483-1486, Ueno,H.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Multiple Sclerosis and Cannabis: A Cognitive and Psychiatric Study
Neurol 71:164-169, Ghaffar,O. &Feinstein,A., 2008

Levetiracetam as a Possible Cause of Fulminant Liver Failure
Neurol 71:685-686, Tan,T.C.H.,et al., 2008

Gastrointestinal Bleeding After Acute Ischemic Stroke
Neurol 71:650-655, ODonnell,M.J.,et al., 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neuol 65:1313-1318, Claassen,D.O.,et al, 2008

Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008

Pronouncing Brain Death: Contemporary Practice and Safety of the Apnea Test
Neurol 71:1240-1244, Wijdicks,E.F.M.,et al, 2008

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

Thrombolysis with Alteplase 3-4.5 h After Ischaemic Stroke (SITS-ISTR): An Observational Study
Lancet 372:1303-1309, Wahlgren,N.,et al, 2008

Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke
NEJM 359:1317-1329,1393, Hacke,W.,et al, 2008

Exposure to Antipsychotics and Risk of Stroke: Self Controlled Case Series Study
BMJ 337:616-618,586, Douglas,I.J. &Smeeth,L., 2008

Practice Parameter: The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the AAN & EFNS
Neurol 71:1183-1190, Gronseth,G.,et al, 2008

Cross-Sensitivity of Skin Rashes with Antiepileptic Drug Use
Neurol 71:1527-1534, Hirsch,L.J.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease
Stroke 39:497-502, Vergouwen,M.D.I.,et al, 2008

Long-Term Outcome in PCNSL Patients Treated with High-Dose Methotrexate and Deferred Radiation
Neurol 70:401-402, Gerstner,E.R.,et al, 2008

Does Cervical Manipulative Therapy Cause Vertebral Artery Dissection and Stroke?
The Neurologist 14:66-73, Miley,M.L.,et al, 2008

Gadolinium-Enhanced MR Cisternography to Evaluate Dural Leaks in Intracranial Hypotension Syndrome
AJNR 29:116-121, Albayram,S.,et al, 2008

Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians
Stroke 39:227-230,7, Gattellari,M.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Progressive Bone Deficit in Epilepsy
Neurol 70:170-176,166, Sheth,R.D.,et al, 2008

Deep Brain Stimulation in 18 Patients With Severe Gilles de la Tourette Syndrome Refractory to Treatment: The Surgery and Stimulation
JNNP 79:136-142,111, Servello,D.,et al, 2008

Effect of Neurologic Complications on Outcome After Heart Transplant
Arch Neurol 65:226-231, van de Beek,D.,et al, 2008

Oxcarbazepine in Migraine Headache: A Double-Blind, Randomized, Placebo-Controlled Study
Neurol 70:548-555, Silberstein,S.,et al, 2008

Polymyalgia Rheumatica
BMJ 336:765-769, Michet,C.J. &Matteson,E.L., 2008

Psychogenic Tremor Occurring After Deep Brain Stimulation Surgery for Essential Tremor
Neurol 70:1498-1499, McKeon,A.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients
AJNR 29:781-785, Suh,D.C.,et al, 2008

Intracerebral Hemorrhage Associated with Use of Tadalafil (CIALIS)
Neurol 70:1289-1290, Gazzeri,R.,et al, 2008

A longitudinal Study of Drivers With Alzheimer Disease
Neurol 70:1171-1178, Ott, B.R.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008



Showing articles 1400 to 1450 of 8417 << Previous Next >>